Literature DB >> 28220022

Using Metaphors to Explain Molecular Testing to Cancer Patients.

Ana P M Pinheiro1,2, Rachel H Pocock1,2, Margie D Dixon1,2, Walid L Shaib1,2, Suresh S Ramalingam1,2, Rebecca D Pentz3,2.   

Abstract

BACKGROUND: Molecular testing to identify targetable molecular alterations is routine practice for several types of cancer. Explaining the underlying molecular concepts can be difficult, and metaphors historically have been used in medicine to provide a common language between physicians and patients. Although previous studies have highlighted the use and effectiveness of metaphors to help explain germline genetic concepts to the general public, this study is the first to describe the use of metaphors to explain molecular testing to cancer patients in the clinical setting.
METHODS: Oncologist-patient conversations about molecular testing were recorded, transcribed verbatim, and coded. If a metaphor was used, patients were asked to explain it and assess its helpfulness.
RESULTS: Sixty-six patients participated. Nine oncologists used metaphors to describe molecular testing; 25 of 66 (38%) participants heard a metaphor, 13 of 25 (52%) were questioned, 11 of 13 (85%) demonstrated understanding and reported the metaphor as being useful. Seventeen metaphors (bus driver, boss, switch, battery, circuit, broken light switch, gas pedal, key turning off an engine, key opening a lock, food for growth, satellite and antenna, interstate, alternate circuit, traffic jam, blueprint, room names, Florida citrus) were used to explain eight molecular testing terms (driver mutations, targeted therapy, hormones, receptors, resistance, exon specificity, genes, and cancer signatures).
CONCLUSION: Because metaphors have proven to be a useful communication tool in other settings, these 17 metaphors may be useful for oncologists to adapt to their own setting to explain molecular testing terms. The Oncologist 2017;22:445-449Implications for Practice: This article provides a snapshot of 17 metaphors that proved useful in describing 8 complicated molecular testing terms at 3 sites. As complex tumor sequencing becomes standard of care in clinics and widely used in clinical research, the use of metaphors may prove a useful communication tool, as it has in other settings. Although this study had a small sample, almost all of the patients who were exposed to metaphors in explaining molecular testing reported it as being helpful to their understanding. These 17 metaphors are examples of potentially useful communication tools that oncologists can adapt to their own practice. © AlphaMed Press 2017.

Entities:  

Keywords:  Communication; Comprehension; Metaphor; Molecular sequencing; Physician‐patient relationship

Mesh:

Year:  2017        PMID: 28220022      PMCID: PMC5388373          DOI: 10.1634/theoncologist.2016-0270

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  21 in total

1.  From sequencing to annotating: extending the metaphor of the book of life from genetics to genomics.

Authors:  Iina Hellsten
Journal:  New Genet Soc       Date:  2005-12

2.  Clinical geneticists' and genetic counselors' views on the communication of genetic risks: a qualitative study.

Authors:  Lidewij Henneman; Theresa M Marteau; Danielle R M Timmermans
Journal:  Patient Educ Couns       Date:  2008-06-25

3.  Effective communication with cancer patients. The use of analogies--a suggested approach.

Authors:  C L Olweny
Journal:  Ann N Y Acad Sci       Date:  1997-02-20       Impact factor: 5.691

4.  Searching for the new normal: exploring the role of language and metaphors in becoming a cancer survivor.

Authors:  Lynda Appleton; Maria Flynn
Journal:  Eur J Oncol Nurs       Date:  2014-04-29       Impact factor: 2.398

5.  Metaphorically transmitted diseases. How do patients embody medical explanations?

Authors:  C E Mabeck; F Olesen
Journal:  Fam Pract       Date:  1997-08       Impact factor: 2.267

Review 6.  The use of metaphor in discourse about cancer: a review of the literature.

Authors:  Kristine J Harrington
Journal:  Clin J Oncol Nurs       Date:  2012-08       Impact factor: 1.027

7.  Genomic testing in cancer: patient knowledge, attitudes, and expectations.

Authors:  Phillip S Blanchette; Anna Spreafico; Fiona A Miller; Kelvin Chan; Jessica Bytautas; Steve Kang; Philippe L Bedard; Andrea Eisen; Larissa Potanina; Jack Holland; Suzanne Kamel-Reid; John D McPherson; Albiruni R Razak; Lillian L Siu
Journal:  Cancer       Date:  2014-06-24       Impact factor: 6.860

8.  Can metaphors and analogies improve communication with seriously ill patients?

Authors:  David Casarett; Amy Pickard; Jessica M Fishman; Stewart C Alexander; Robert M Arnold; Kathryn I Pollak; James A Tulsky
Journal:  J Palliat Med       Date:  2010-03       Impact factor: 2.947

9.  Use of metaphors about exome and whole genome sequencing.

Authors:  Sarah C Nelson; Julia M Crouch; Michael J Bamshad; Holly K Tabor; Joon-Ho Yu
Journal:  Am J Med Genet A       Date:  2016-01-29       Impact factor: 2.802

10.  Metaphor and medicine: narrative in clinical practice.

Authors:  Jack Coulehan
Journal:  Yale J Biol Med       Date:  2003
View more
  3 in total

1.  Multilevel Influences on Patient-Oncologist Communication about Genomic Test Results: Oncologist Perspectives.

Authors:  Suzanne C O'Neill; Kathryn L Taylor; Jonathan Clapp; Jinani Jayasekera; Claudine Isaacs; Deena Mary Atieh Graham; Stuart L Goldberg; Jeanne Mandelblatt
Journal:  J Health Commun       Date:  2018-08-21

2.  Understanding Immunotherapy Terminology: An Analysis of Provider-Patient Conversations.

Authors:  Shannon Blee; Bari Rosenberg; Jeffrey M Switchenko; Rachel Hianik; Mary Catherine Thomson; Margie Dixon; Mehmet Asim Bilen; Rebecca D Pentz
Journal:  Immunomedicine       Date:  2021-09-02

3.  Physician Communication and Patient Understanding of Molecular Testing Terminology.

Authors:  Shannon M Blee; Rachel Pocock Shah; Ana P M Pinheiro; Jeffrey Switchenko; Margie Dixon; Taofeek K Owonikoko; Charles E Hill; Stephen M Szabo; Rebecca D Pentz
Journal:  Oncologist       Date:  2021-08-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.